» Authors » Angel Vila-Corcoles

Angel Vila-Corcoles

Explore the profile of Angel Vila-Corcoles including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 53
Citations 880
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Vila-Corcoles A, Satue-Gracia E, Ochoa-Gondar O, Torrente-Fraga C, Gomez-Bertomeu F, Vila-Rovira A, et al.
J Clin Hypertens (Greenwich) . 2020 Jul; 22(8):1379-1388. PMID: 32710674
The use of some anti-hypertensive drugs in the current COVID-19 pandemic has become controversial. This study investigated possible relationships between anti-hypertensive medications use and COVID-19 infection risk in the ambulatory...
12.
Vila-Corcoles A, Ochoa-Gondar O, Torrente-Fraga C, Vila-Rovira A, Satue-Gracia E, Hospital-Guardiola I, et al.
Rev Esp Salud Publica . 2020 Jun; 94. PMID: 32588837
Objective: Population-based data on the current Covid-19 pandemic is scarce. This study investigated incidence and risk to suffer Covid-19 by baseline underlying conditions in people ≥50 years in Tarragona region...
13.
Vila-Corcoles A, Hospital I, Ochoa-Gondar O, Satue E, de Diego C, Vila-Rovira A, et al.
Vaccine . 2019 Nov; 38(5):1170-1180. PMID: 31759735
Background: Clinical benefits using the 23-valent pneumococcal polysaccharide vaccine (PPsV23) or the 13-valent pneumococcal conjugate vaccine (PCV13) in adults are controversial. This study investigated clinical effectiveness for both PPsV23 and...
14.
Vila-Corcoles A, Ochoa-Gondar O, de Diego C, Satue E, Vila-Rovira A, Aragon M
Euro Surveill . 2019 Jul; 24(29). PMID: 31339099
BackgroundRecent published data on pneumococcal vaccination coverages among adults are scarce.AimTo update on pneumococcal vaccination uptakes among middle-aged and older adults in Catalonia.MethodsWe conducted a population-based retrospective observational study including...
15.
Forcadell M, Vila-Corcoles A, de Diego C, Ochoa-Gondar O, Satue E
Eur J Prev Cardiol . 2018 Jul; 25(17):1822-1830. PMID: 30019923
Background: Population-based data about the epidemiology of acute myocardial infarction is limited. This study investigated incidence and mortality of acute myocardial infarction in older adults with specific underlying chronic conditions...
16.
Vila-Corcoles A, Ochoa-Gondar O, de Diego C, Satue E, Aragon M, Vila-Rovira A, et al.
BMC Infect Dis . 2018 Apr; 18(1):196. PMID: 29699550
Background: Benefits using the 13-valent pneumococcal conjugate vaccine (PCV13) in adults are controversial. This study investigated clinical effectiveness of PCV13 vaccination in preventing hospitalisation from pneumonia among middle-aged and older...
17.
Ochoa-Gondar O, Vila-Corcoles A, de Diego C, Satue E, Vila-Rovira A, Aragon M
Aten Primaria . 2018 Jan; 50(9):553-559. PMID: 29373143
Objectives: To know antipneumococcal vaccination coverages among Catalonian adults and evaluate the adequacy of vaccine use according to 3 distinct current vaccination guidelines. Design: Population-based cross-sectional study. Setting: Primary Health...
18.
Vila-Corcoles A, Ochoa-Gondar O, Satue E, de Diego C, Vila-Rovira M, Jariod M
Rev Esp Salud Publica . 2017 Mar; 91. PMID: 28300793
Objective: Published data about prevalence of distinct risk condictions for pneumococcal disease is scarce. This study investigated the prevalence of distinct risk conditions for pneumococal disease in Catalonian adults and...
19.
Vila-Corcoles A, Ochoa-Gondar O
Aten Primaria . 2016 Oct; 49(2):111-117. PMID: 27765456
There are currently two anti-pneumococcal vaccines available for use in adults: the classical 23-valent polysaccharide pneumococcal vaccine (PPV23) and the new 13-valent pneumococcal conjugate vaccine (PCV13). The main advantage of...
20.
Vila-Corcoles A, Ochoa-Gondar O, Hospital I, de Diego C, Satue E, Blade J, et al.
Hum Vaccin Immunother . 2016 Jul; 12(11):2953-2958. PMID: 27454779
There is scarce data about pneumococcal vaccination coverages among adults in recent years. We investigated current pneumococcal vaccination coverages in Catalonia, Spain, with a cross-sectional population-based study including 2,033,465 individuals...